Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Appendix: UK trials that were linked by CTSU-ctfs

  • Ovarian Irradiation Trial, Part I: Entry JUN-1948 to DEC-1950; 189 participants; Principal Investigator Dr Paterson; Reported in: J Faculty Radio 10: 175-80 1959 (no further follow-up).
  • Addenbrooke's Stage II: Entry OCT-1958 to MAY-1965 233 participants; Principal Investigator Dr John Haybittle ; Reported in: Lancet 2:1086-7 1971 (no further follow-up).
  • Cardiff Trial: Entry SEP-1967 to JUN-1973; 200 participants; Principal Investigator Margaret Maureen Roberts; Reported in: Ann Surg Oncol 6(5):455-60 1999 (no further follow-up).
  • Lister Trial: Entry SEP-1969 to SEP-1976; 534 participants; Principal Investigator L. Turner; Reported in: Ann R Coll Surg Engl 63(4)239-43 1981.
  • Regional Breast Study 1 & 2: Entry MAR-1970 to OCT-1975; 1012 participants; Principal Investigator J. P. Lythgoe; 279 participants still being followed up in 1990 were linked in 2001; Reported in: Br J Surg 69(12) 693-6 1995.
  • King's/Cambridge Radiotherapy (C.R.C. 1): Entry MAY-1970 to JUN-1975; 2800 participants; Principal Investigator M. Baum; a number of UK participants were linked in 1999; Reported in: World J Surg. 1994 Jan-Feb;18(1):117-22.
  • Tamoxifen trial: Entry NOV-1976 to JUL-1982; 1005 participants; Principal Investigator Dr G. Ribeiro; Reported in: Br J Cancer 62(Suppl 12):16 1990.
  • CMF/Tamoxifen Trial UK: Entry MAY-1978 to MAR-1984; 118 participants; Principal Investigator Dr L.F.N. Senanayake; Reported in: Lancet 2 (8412):1148-9 1984.
  • C.R.C. Adjuvant Breast Trial (C.R.C. 2): Entry SEP-1980 to APR-1986; 2230 participants; Principal Investigator M. Baum; a number of UK participants were linked in 1999; Reported in: Br J Cancer 57(6):604-7 1988.
  • Conservation Trial: Entry OCT-1982 to DEC-1987; 708 participants; Principal Investigator Dr G. Ribeiro; Reported in: Clin Oncol R Coll Radiol 5(5):278-83, 1993.
  • Yorkshire Conservation Trial: Entry JUL-1986 to JUN-1990; 175 participants; Principal Investigator Prof David J. Dodwell; Reported in: Clin Oncol 17:618-622 2005.
  • ALMANAC Trial: Entry NOV-1999 to OCT-2003; 1031 participants; Principal Investigator Prof Robert E. Mansel; Reported in: J Clin Oncol 27:1177-83 2009.
  • East Anglia Sentinel Node Biopsy Trial: Entry NOV-1999 to FEB-2003 (298 participants; Principal Investigator Prof A. D. Purushotham; Reported in: J Clin Oncol 23(19):4312-21 2005.
  • BASO II: MAR-1992 to OCT-2000; 1158 participants; Principal Investigator Prof Roger Blamey; Reported in: Eur J Cancer 49(10):2294-302 2013.
  • C.R.C. Under 50s Trial (part of 'ZIPP'): Entry OCT-1987 to MAR-1999; 208 participants; Principal Investigator Prof M. Baum; Reported in: J Natl Cancer Inst 101(5):341-9 2009.
  • C.R.C. Over 50s Trial: Entry JAN-1987 to FEB-1997; 3888 participants; Principal Investigator Prof M. Baum; Reported in: J Clin Oncol 29(13):1657-63 2011.
  • A.N.Z. DCIS Trial: Entry MAY-1990 to OCT-1998; 1514 participants in UK; Principal Investigator in UK Prof Jack Cuzick; Reported in: Lancet Oncol 12(1):21-9 2011.
  • ATAC Trial: Entry JUL-1996 to MAR-2000; 9366 participants; Principal Investigator Prof M. Baum; Reported in: Lancet Oncol 11(12):1135-41 2010)